Moreover, although inhibition of the RyR2 channel in the heart could be a promising anti-heart failure or anti-CPVT1 approach, it could give rise to serious extra-cardiac side-effects because of a strong inhibitory effect of dantrolene on RyR1 and RyR3 channels. This evidence concerns the gene RYR1 and heart failure.